chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm was sore) and PYREXIA (fever) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm was sore) and PYREXIA (fever). At the time of the report, DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm was sore) and PYREXIA (fever) had resolved. No Concomitant Medication was provided. No treatment information was provided.
sick all night; stomach cramps; feeling nauseous but haven't thrown up; slight headache; having chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick all night), ABDOMINAL PAIN UPPER (stomach cramps), NAUSEA (feeling nauseous but haven't thrown up), HEADACHE (slight headache) and CHILLS (having chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ILLNESS (sick all night), ABDOMINAL PAIN UPPER (stomach cramps), NAUSEA (feeling nauseous but haven't thrown up), HEADACHE (slight headache) and CHILLS (having chills). At the time of the report, ILLNESS (sick all night), ABDOMINAL PAIN UPPER (stomach cramps), NAUSEA (feeling nauseous but haven't thrown up), HEADACHE (slight headache) and CHILLS (having chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided  No treatment medications provided   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up received on 4th MAY 2021 contains no new information
constant diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 19Feb2021 at 17:30 (at the age of 79-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201)  via an unspecified route of administration in the left arm on an unspecified date ; as a single dose for COVID-19 immunisation. Medical history included arthritis, two hip replacement, two knee replacement, shots in hands and feet every three months and low kidney function. Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Feb2021 at 11:00 the patient experienced constant diarrhea. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of diarrhea and included treatment with unspecified antibiotic prescribed by the doctor. The clinical outcome of the event constant diarrhea was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Elevated resting heart rate noticed by my fitness tracker. Resting HR was 115-120 BPM beginning at 1pm on 11/19. Checked into ER 3pm, lots of tests which ask came back negative (covid, flu, pulmonary embolism, blood clot, etc.) ER administered fluids, pulse lowered to 95-99. Discharged from ER with no clear cause at 1am on 11/20
Second injection at 1:00 PM- around 7:00 PM * 6 hours later ) Fever, chills, nausea, skin is sensitive, loss of appetite, and severe tiredness. As of 24 hours after injection, side effects remain the same or worse. Severe chills throughout the night, only waking to urinate.  He did wake up, took a shower only to have alot of coughing and chest discomfort.If he is not better soon, we will take a trip to the ER.
Information has been received from a physician concerning a 9 year old male who on 06-FEB-2002 was vaccinated with the first dose of MMR II. On 21-JUN-2004, the patient was vaccinated with the second dose of MMR II. On 02-JAN-2010, the patient experienced mumps. Date of mumps diagnosis reported as 31-DEC-2009. The patient was afebrile. The patient had right parotitis. Parotitis count was 122. At the time of this report, the patient's outcome was not reported. Follow-up information was received from the physician indicating that on 06-DEC-2009 the 8 year old patient developed mumps. The date diagnosed was changed to 07-DEC-2009. The patient had left parotitis. On 07-DEC-2009 the first blood work revealed IgM<1:10, IgG 8.12 and serum amylase 397. No further information is available.
not feeling well; flu like symptoms; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), INFLUENZA LIKE ILLNESS (flu like symptoms) and HEADACHE (headache) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reported.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MALAISE (not feeling well), INFLUENZA LIKE ILLNESS (flu like symptoms) and HEADACHE (headache). At the time of the report, MALAISE (not feeling well), INFLUENZA LIKE ILLNESS (flu like symptoms) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Patient's contact updated
she presneted 10/23 for a blood pressure check up and in the course of that we did an annual flu shot for her. See the flu shot note:        10/23/08 The following questions were answered by the patient: Are you currently ill with a moderate or severe illness? No Temperature: __ Are you allergic to eggs or egg products? No Have you ever been paralyzed by Guillain Barre Syndrome? No Have you ever had a severe allergic reaction after getting the flu vaccine? (difficulty breathing, aiway swelling, hives, etc.) No Patient was given the opportunity to ask questions prior to immunization and have them answered to their satisfaction: _Yes Manufacturer: Aventis Lot #: U2805AA Expiration Date: 06/30/2009 Preservative Free _No Vaccine information sheet given: Yes VIS Pub. Date: 07/24/08 Dose: 0.5 ml Site: left deltoid  She then reproted on 10/31 with swelling in hands and feet and rash. It looked like allergic reaction. she was not ill so we treated her as an out patient. she called a few days later and was getting worse. I had her admitted to hospital. I have not received a formal report. One of the diagnosis that was on the top of the list was influenza vaccine vasculitis. she was not getting better. The Dr. that was caring for her reported that her dau, a hospice nurse talked to her about what was going on and patient decieded to not have any more needle pokes or evaluation. She was sent to nursing home and died the next day. 12/29/08-records received for DOS 11/3-11/12/08-DC DX: likely vasculitis. acute renal failure, resolving. Presented with C/O weakness, seen 3 days prior with swelling in fingertips and lower extremities. Hyperkalemic. Dehydrated. Hyponatremia. Purpura of feet and lower extremities. 11/21/08 Death certificate states COD as acute renal failure with vasculitis & immunologic reaction as contributing factors.
Initial report received on 30Jun06 from a health care professional. A 66 yr old female pt with a past medical history of hypertension and hyperlipidemia had received an IM injection of Typhim VI, lot number Z0425, in the left arm; and a SC injection of YF vax, lot UE805AA, in the left arm; and an IM injection of Tetanus Diphtheria vaccine, lot TD 162, in the left arm; and a SC injection of IPOL, lot number Y0824, in the right arm; and an IM injection of Twinrix, lot number AHABB058CA, in the right arm on 19Jun06. The pt developed a hard nodule at the injection site on the left arm three days post immunization. The pt was medically evaluated three times and was treated with unspecified antibiotics. The recovery status of the pt was reported as not recovered. Follow up report received on 26Jul06 from a health care professional. It was reported that the nodule at the injection site was actually a cyst. It was later discovered that the pt had skin cancer and therefore did not have a reaction to the vaccination. No other information was provided at this time. Based upon this new information, this case has been upgraded to serious. (OMIC)
2 days post vax, pt presented with redness at injection site, 3.5 X 4.5 cm in diameter. Pt experienced soreness at injection site and increased temperature at site stated by pt and assessed by RN.
One week after receiving my first shot of Moderna Covid vaccine, 3/17/2021,   my upper right arm (vaccine site) became red, swollen, hot and itchy. It?s a very large area.  I took Benadryl. As of this morning,  03/18/2021, it is still the same. After a Google search, it looks like ?Covid Arm?.
PATIENT DESCRIBED HAVING THE FOLLOWING: FEVER OVER 103 DEGREES F FOR MORE THAN 3 DAYS, BODY ACHES ALL OVER, TREMORS, SWOLLEN GUMS, ORAL ULCERS, COLD SORES ON NOSE  -  TOOK APPROXIMATELY A WEEK FOR THIS ALL TO RESOLVE - SHE SPOKE WITH HER PROVIDER AND WAS INFORMED TO NOT TO GET ANY MORE COVID VACCINES  HER 1ST 2 COVID SHOTS WERE THE PFIZER VACCINE THEN SHE RECEIVED MODERNA FOR HER 3RD (BOOSTER) SHOT
Began feeling feverish, achy with chills and blurry vision. Gradually worsening with light sensitivity (wore sunglasses indoors to reduce eye pain.) Temperature 99.5 at 15:00 and 100.2 at 20:15. Took two Ibuprofen and slept through to following morning. Awoke mostly symptom-free around 10 am. Continue to feel unusually cold. Treating this by wearing a warm sweater indoors. N.B. Light sensitivity may possibly be attributed to being under florescent lights (see Allergies and Reactions above) for more than an hour while waiting for shot and waiting to check for possible reaction to the shot.
5 minutes after vaccine, patient experienced flushing of chest, neck and face followed by urticaria.  Tachycardia and hypertension with feeling of impending doom.  Responded to Benadryl 50mg IV, Famotidine 20mg IV and Solumderol 40mg IV.  Symptoms lasted approximately 1 hour after they started. Rx for prednisone taper and famotidine to continue for next week as well as OTC Zyrtec 20mg BID.
Almost continuous palpitations for two nights, then sporadic but decreasing frequency ever since.  Some shortness of breath with low level of exertion.  Saw cardiologist and and have Holter monitor, having multiple PVCs, cardio says benign but is doing US today to check for carditis.
headache; little bit of nausea; fatigue; arm was sore; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (headache), NAUSEA (little bit of nausea), FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2ALCHD) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced HEADACHE (headache), NAUSEA (little bit of nausea), FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore). At the time of the report, HEADACHE (headache), NAUSEA (little bit of nausea) and FATIGUE (fatigue) had resolved and VACCINATION SITE PAIN (arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided No concomitant medication was provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient passed out 10 mins after receiving vaccine. Pharmacist stated that 911 was called, also said patient was sweating profusely.
Extreme pain in upper arm (from shoulder to elbow), blackouts, dizziness to the point of falling down, difficulty breathing
Developed rhinorrhea/URI sx 24 hrs after vaccine and fever to 102 degrees 48-72 hrs after vaccine with URI sx and mild loose stools.
PT came stating she got adverse reaction of booster pfizer she got yesterday, swelling and soreness at left armpit. consulted pt to use warm compression and advil , and directed to report to v-safe. and will do scrt .
Patient presented to emergency department on 10/27/2021 with shortness of breath. She was found to be COVID-19 positive and admitted for further management. She was treated with dexamethasone, remdesivir, and supplemental oxygen. She was discharged on 11/6/2021 to skilled nursing facility.
Soreness & a little swelling,  itchy for the 1st 2 days, it seem to be ok just sore.  By 5 or 6 day the area was warm to the touch red swollen & what looked like welts & itchy.
Patient stated given flumist on 11/24/04. Stated on 11/25/04 developed red pimple area on stomach, arms, and thighs, when scratched became welts.
Fever, seen for dehydration 6/20/11, neck stiffness, arm hurting.
her face and ears got really hot; This is a spontaneous report from a contactable consumer or other non-Health care Professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9262), dose 1 via an unspecified route of administration on an unspecified date as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Callback to consumer who has already reported her experience(unable to confirm spelling of patient's name as she was quick to get off the phone). She reports that after her first dose of the Pfizer-Biontech COVID 19 vaccine patient experienced her face and ears got really hot. She wants to know if she can treat with aspirin or Tylenol better. Patient asked that she can use antipyretics before or after vaccination with the Pfizer-BioNTech COVID-19 vaccine. COVID 19 first shot-I had a reaction and I spoke to the girl before and told her what it was-face and my ears really hot. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
Initial unsolicited report received from the literature on 01 June 2016. This case is linked to Case is linked with 2016SA108588, 2016SA108584 and 2016SA108560 (same literature). The following is verbatim from the article: Background. Many adult immunization schedules recommend that tetanus and diphtheria vaccination be performed every 10 years. In light of current epidemiological trends of disease incidence and rates of vaccine-associated adverse events, the 10-year revaccination schedule has come into question. Methods. We performed cross-sectional analysis of serum antibody titers in 546 adult subjects stratified by age or sex. All serological results were converted to international units after calibration with international serum standards. Results. Approximately 97% of the population was seropositive to tetanus and diphtheria as defined by a protective serum antibody titer of 0.01 IU/mL. Mean antibody titers were 3.6 and 0.35 IU/mL against tetanus and diphtheria, respectively. Antibody responses to tetanus declined with an estimated half-life of 14 years (95% confidence interval, 11-17 years), whereas antibody responses to diphtheria were more long-lived and declined with an estimated half-life of 27 years (18-51 years). Mathematical models combining antibody magnitude and duration predict that 95% of the population will remain protected against tetanus and diphtheria for 30 years without requiring further booster vaccination. Conclusions. These studies demonstrate that durable levels of protective antitoxin immunity exist in the majority of vaccinated individuals. Together, this suggests that it may no longer be necessary to administer booster vaccinations every 10 years and that the current adult vaccination schedule for tetanus and diphtheria should be revisited. This case involves a 61-year-old patient (gender not reported) who was vaccinated with a dose of TDAP (manufacturer: unknown) (batch number, expiration date, dose, site and route of administration were not reported) on an unspecified date. The patient medical history and concomitant medications were not reported. On an unspecified date following the vaccination the patient lacked immunity to both (diphtheria and tetanus) toxins. A serum antibody titer was performed (results not provided). Other laboratory data and corrective treatment was not reported. Outcome of the event was not reported. Documents held by sender: none.
Very mild initial symptoms. Approximately 12 days after this shot Urticaria + Dermatographism all over body, ongoing skin rash/skin writing/mild itchiness.  Never experienced this before in life, or with any of the previous 3 COVID vaccine shots.
Patient is complaining of a sore arm from shot on 10/17/07.  She saw her Dr. and he told her he thought possibly she was injected into a tendon.  She does not remember where she received shot.  MD felt arm & said he felt a lump on her tendon.
This spontaneous report was received from a registered nurse via medical assistant and refers to a 13-month-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 16-OCT-2017, the patient was vaccinated with improperly stored M-M-R II (lot # M034387; expiry date: 19-JUL-2018) (dosing details were not provided) for prophylaxis. Temperature excursion details of the vaccine were not provided. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459: US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014651: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. No concurrent condition or medical history was reported. On 24-NOV-2015, the patient was accidentally vaccinated with RECOMBIVAX HB (dose and route of administration not reported) and PEDIARIX. No concomitant therapy was reported. No adverse effects was reported. The outcome of the event was unknown. No product quality issue was involved. Additional information has been requested.
10 minutes after receiving the Bexsero vaccine the patient was in the exam room with her mother when she became nauseous and dizzy. Per the mother she then fell forward from the exam table and impacted her face on the floor sustaining an abrasion to her upper lip. Subsequently she had several episodes of clonic tremulous activity of her upper extremities lasting approximately 15 seconds each time within a period of 15 minutes. This patient was transported to the emergency room where she had one additional episode of the tremulous upper extremity activity. She continued to breath through these events and had immediate return to baseline mentation.
Patient complained of anxiety, palpitations, and tachypnea.   Patient was laid supine, VS monitored, reassurance, fluids, and snack. Went home after feeling better. Stated some mild nausea the day after.
Information has been received from a consumer concerning to her 17 year old daughter who on 15-JUL-2009 was vaccinated with the first dose of GARDASIL (Lot # not provided) 0.5 ml. Concomitant therapy included NASONEX. The patient was scheduled to receive the second dose on 16-SEP-2009. On 12-SEP-2009 the patient experienced cough and stuffy nose. The patient did not seek medical attention. At the time of  this report, the patient was not recovered. No further information is available.
Chronic flu like symptoms, weakness/pain in left arm, chest tightness and shortness or breath.
Initial case received from a health care professional (physician's assistant) on 26 March 2014. A 33-year-old male patient, with a history of left shoulder surgery, received an intramuscular left deltoid injection of ADACEL (lot number U4837AA) on 11 March 2014. On unspecified time post vaccination, he began experiencing severe myalgia and malaise with body aches, headache, and muscle aches both lower extremities and elbows. On 21 March 2014 the patient reported feeling cold for two hours, followed by sweats and a temperature of 100 degrees Fahrenheit. The patient was evaluated by his physician on 24 March 2014. According to the reporter, the patient's symptoms were "severe to the point that the patient had to be seen in a wheelchair". Laboratory testing performed on an unspecified date were as follows: white blood count 18,000; sedimentation rate 121; C-reactive protein 30.5; increased alkaline phosphatase, liver enzymes, monocytes, neutrophils, and eosinophils. Hepatitis A, B, and C testing and liver ultrasound were negative. The patient was to be evaluated by a rheumatologist; results of the consultation were not reported. According to the reporter, the physician was "ruling out serum sickness versus infection". Outcome was unknown. Documents held by sender: None.
Pt had 3 shot series: 1/3/17: M034780 (exp 4-15-19), 9/28/16: M016193 (exp 4-24-18), and 8/9/16 M)11840 (exp 2-1-18.  No h/o sexual contact at all, no intimate skin to skin contact.  Dx condyloma accuminata June 18, 2019.